Crescita Therapeutics (CTX) Stock Chart & Stock Price History C$0.50 0.00 (0.00%) As of 06/13/2025 Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesInsider TradesBuy This Stock Crescita Therapeutics Stock Price Performance The Crescita Therapeutics (CTX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 16.28%, with a year-to-date return of -13.79%. In the past month, the stock has decreased 3.85%, reflecting recent market activity. As of the latest close, Crescita Therapeutics traded at C$0.50 with a market cap of C$9.20 million and volume of 1,500 shares. Five years ago, the stock traded at C$0.64, representing a 21.88% decrease over that period. At the time, it had a market cap of C$15.12 million and a volume of 0 shares. Receive CTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Crescita Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+4.17%1 Month Performance-3.85%3 Month PerformanceN/AYear-To-Date Performance-13.79%1 Year Performance+16.28%5 Year PerformanceN/A CTX Stock Chart for Saturday, June, 14, 2025 CTX Chart by TradingView Crescita Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/13/2025C$0.50C$0.50C$0.50C$0.501,500 shsC$9.20 million06/12/2025C$0.50C$0.50C$0.50C$0.501,500 shsC$9.20 million06/11/2025C$0.48C$0.50+4.17%C$0.50C$0.501,500 shsC$9.20 million06/10/2025C$0.48C$0.48C$0.48C$0.4813,000 shsC$8.84 million06/09/2025C$0.47C$0.48+2.13%C$0.49C$0.4817,001 shsC$8.84 million06/06/2025C$0.54C$0.47-12.96%C$0.52C$0.45109,732 shsC$8.65 million06/05/2025C$0.53C$0.54+1.89%C$0.54C$0.544,000 shsC$9.94 million06/04/2025C$0.53C$0.53C$0.53C$0.531,000 shsC$9.76 million06/03/2025C$0.52C$0.53+1.92%C$0.54C$0.5310,821 shsC$9.76 million06/02/2025C$0.50C$0.52+4.00%C$0.52C$0.4815,100 shsC$9.57 million Get the Latest News and Ratings for CTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Crescita Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/30/2025C$0.50C$0.50C$0.50C$0.50520 shsC$9.20 million05/29/2025C$0.50C$0.50C$0.51C$0.505,105 shsC$9.20 million05/28/2025C$0.51C$0.50-1.96%C$0.51C$0.505,105 shsC$9.20 million05/27/2025C$0.54C$0.51-5.56%C$0.54C$0.4946,531 shsC$9.39 million05/26/2025C$0.54C$0.54C$0.54C$0.5413,000 shsC$9.94 million05/23/2025C$0.54C$0.54C$0.54C$0.5210,611 shsC$9.94 million05/22/2025C$0.54C$0.54C$0.54C$0.543,500 shsC$9.94 million05/21/2025C$0.54C$0.54C$0.54C$0.54786 shsC$9.94 million05/20/2025C$0.51C$0.54+5.88%C$0.54C$0.525,515 shsC$9.94 million05/16/2025C$0.51C$0.51C$0.52C$0.509,020 shsC$9.39 million05/15/2025C$0.52C$0.51-1.92%C$0.52C$0.509,020 shsC$9.39 million05/14/2025C$0.53C$0.52-1.89%C$0.53C$0.5269,710 shsC$9.57 million05/13/2025C$0.55C$0.53-3.64%C$0.55C$0.5310,202 shsC$9.76 million Related Companies LABS Stock Price Chart DB Stock Price Chart VM Stock Price Chart CWEB Stock Price Chart MPH Stock Price Chart WLLW Stock Price Chart ENTG Stock Price Chart AQS Stock Price Chart DHT.UN Stock Price Chart Receive CTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Crescita Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (TSE:CTX) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredOil Hits $74 - $100 Next?Oil Jumps 8.5% on Middle East Crisis Trump at Oil Fields Oil surged 8.5% to $74/barrel after Israel's Ir...The Oxford Club | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Crescita Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Crescita Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
